PulseAugur
EN
LIVE 10:36:51
ENTITY Harvard Medical School

Harvard Medical School

PulseAugur coverage of Harvard Medical School — every cluster mentioning Harvard Medical School across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
13
13 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
3
3 over 90d
TIER MIX · 90D
TOPICS
RELATIONSHIPS
SENTIMENT · 30D

4 day(s) with sentiment data

RECENT · PAGE 1/1 · 13 TOTAL
  1. TOOL · CL_98619 ·

    Longevity field's cellular reprogramming theory faces human trial reality check

    A groundbreaking human trial has begun for a gene therapy aimed at partially reprogramming older cells to a younger state, a development that could validate key theories in the longevity medicine field. This early-stage…

  2. COMMENTARY · CL_96831 ·

    AI tool aids DVT diagnosis, highlighting patient advocacy potential

    A personal account highlights how an AI health tool, trained on personal medical records, helped identify potential deep vein thrombosis (DVT) when initial medical consultations did not. The AI flagged the condition, pr…

  3. COMMENTARY · CL_96657 ·

    Singapore education debate reignited by Harvard speech on late bloomers

    A recent Harvard speech by a Singaporean student has reignited a debate about the country's highly competitive education system and its ability to accommodate students who develop later. The student, who delivered an ad…

  4. COMMENTARY · CL_87749 ·

    AI adoption is driving up healthcare costs, not lowering them

    Artificial intelligence is poised to increase healthcare costs due to its use in administrative software and scribes that more thoroughly document patient care, leading to higher billing complexity. While AI could event…

  5. COMMENTARY · CL_80845 ·

    OpenAI Files for $1 Trillion IPO Amid AI and Longevity News

    MIT Technology Review's daily newsletter, The Download, covers significant developments in AI and longevity research. The publication highlights OpenAI's confidential filing for a US IPO, potentially valuing the company…

  6. RESEARCH · CL_80633 ·

    David Sinclair to test oral rejuvenation drug in XPrize competition

    Longevity scientist David Sinclair is preparing to test an oral drug mixture, code-named SL-100, for whole-body rejuvenation. This initiative is part of a $101 million XPrize competition aimed at restoring individuals t…

  7. COMMENTARY · CL_58148 ·

    Karpathy rebrands 'vibe coding' to 'agentic engineering'

    Andrej Karpathy, a prominent figure in AI development, has evolved his concept of "vibe coding" to "agentic engineering." This new approach emphasizes orchestrating AI agents to write code rather than directly writing i…

  8. RESEARCH · CL_57202 ·

    Senator proposes Medicare cover for elderly fall prevention

    Senator Angus King proposed Medicare coverage for basic bathroom safety equipment to prevent costly fall-related injuries in the elderly. Falls are a leading cause of traumatic brain injury and intracranial hemorrhage i…

  9. RESEARCH · CL_39029 ·

    FDA approves first gene therapy for genetic deafness

    The FDA has approved the first gene therapy designed to treat deafness caused by a specific genetic mutation. This groundbreaking treatment targets the OTOF gene, which is crucial for transmitting sound signals from the…

  10. COMMENTARY · CL_21481 ·

    Cluttered homes negatively impact mental health, sleep, and productivity

    A cluttered home can have a significant negative impact on mental well-being, increasing stress, anxiety, and reducing overall life satisfaction. Research indicates that disorganized living spaces overstimulate the brai…

  11. RESEARCH · CL_10922 ·

    Harvard study: AI model outperforms doctors in emergency room diagnoses

    A recent Harvard study published in Science indicates that OpenAI's o1 model achieved higher accuracy in diagnosing emergency room patients than two human attending physicians. The AI model provided the exact or a very …

  12. SIGNIFICANT · CL_04864 ·

    Anthropic adds Novartis CEO Vas Narasimhan to Board of Directors

    Anthropic's Long-Term Benefit Trust has appointed Vas Narasimhan, CEO of Novartis, to its Board of Directors. Narasimhan's extensive experience in developing and approving new medicines in a highly regulated industry is…

  13. SIGNIFICANT · CL_02276 ·

    OpenAI forms expert council to guide AI well-being and safety

    OpenAI has established an Expert Council on Well-Being and AI, comprising leading researchers in psychology, human-computer interaction, and related fields. This council will advise OpenAI on developing AI systems, such…